Table of Contents Author Guidelines Submit a Manuscript
Advances in Bioinformatics
Volume 2012, Article ID 373506, 13 pages
http://dx.doi.org/10.1155/2012/373506
Research Article

Detecting Cancer Outlier Genes with Potential Rearrangement Using Gene Expression Data and Biological Networks

1Department of Computer Science, University of Calgary, Calgary, AB, Canada T2N 1N4
2Departments of Pathology, Oncology and Molecular Biology and Biochemistry, Faculty of Medicine, University of Calgary, Calgary, AB, Canada T2N 1N4

Received 5 March 2012; Revised 30 April 2012; Accepted 8 May 2012

Academic Editor: T. Akutsu

Copyright © 2012 Mohammed Alshalalfa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. de Klein, A. G. van Kessel, G. Grosveld et al., “A celllular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia,” Nature, vol. 300, no. 5894, pp. 765–767, 1982. View at Google Scholar · View at Scopus
  2. M. Soda, Y. L. Choi, M. Enomoto et al., “Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer,” Nature, vol. 448, no. 7153, pp. 561–566, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Kumar-Sinha, S. A. Tomlins, and A. M. Chinnaiyan, “Recurrent gene fusions in prostate cancer,” Nature Reviews Cancer, vol. 8, no. 7, pp. 497–511, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Squire, “TMPRSS2-ERG and PTEN loss in prostate cancer,” Nature Genetics, vol. 41, no. 5, pp. 509–510, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. F. Berger, M. S. Lawrence, and F. Demichelis, “The genome complexity of primary human prostate cancer,” Nature, vol. 470, pp. 214–220, 2011. View at Google Scholar
  6. R. I. Skotheim, G. O. S. Thomassen, M. Eken et al., “A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis,” Molecular Cancer, vol. 8, pp. 1–2, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Edgren, A. Murumagi, S. Kangaspeska et al., “Identification of fusion genes in breast cancer by paired-end RNA-sequencing,” Genome Biology, vol. 12, no. 1, article R6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Hu, K. Wang, X. He, D. Y. Chiang, J. F. Prins, and J. Liu, “A probabilistic framework for aligning paired-end RNA-seq data,” Bioinformatics, vol. 26, no. 16, pp. 1950–1957, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Wang, D. Singh, Z. Zeng et al., “MapSplice: accurate mapping of RNA-seq reads for splice junction discovery,” Nucleic Acids Research, vol. 38, no. 18, article e178, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. McPherson, F. Hormozdiari, A. Zayed et al., “Defuse: an algorithm for gene fusion discovery in tumor rna-seq data,” PLoS Computational Biology, vol. 7, no. 5, Article ID e1001138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Rubin and A. M. Chinnaiyan, “Bioinformatics approach leads to the discovery of the TMPRSS2:ETS gene fusion in prostate cancer,” Laboratory Investigation, vol. 86, no. 11, pp. 1099–1102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. W. U. Baolin, “Cancer outlier differential gene expression detection,” Biostatistics, vol. 8, no. 3, pp. 566–575, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Li, A. Chaudhuri, J. Chant, and Z. Tang, “PADGE: analysis of heterogeneous patterns of differential gene expression,” Physiological Genomics, vol. 32, no. 1, pp. 154–159, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. A. Tomlins, D. R. Rhodes, S. Perner et al., “Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer,” Science, vol. 310, no. 5748, pp. 644–648, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Tibshirani and T. Hastie, “Outlier sums for differential gene expression analysis,” Biostatistics, vol. 8, no. 1, pp. 2–8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. P. Mpindi, H. Sara, S. Haapa-Paananen et al., “Gti: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasets,” PLoS ONE, vol. 6, no. 2, Article ID e17259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Wu, X. Feng, and L. Stein, “A human functional protein interaction network and its application to cancer data analysis,” Genome Biology, vol. 11, no. 5, article R53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Singh, P. G. Febbo, K. Ross et al., “Gene expression correlates of clinical prostate cancer behavior,” Cancer Cell, vol. 1, no. 2, pp. 203–209, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Tylor, N. Schultz, H. Hieronyymus, and W. Gerald, “Integrative genomic profiling of human prostate cancer,” Cancer Cell, vol. 18, pp. 1–12, 2010. View at Google Scholar
  20. A. D. Darnel, C. J. LaFargue, R. T. Vollmer, J. Corcos, and T. A. Bismar, “TMPRSS2-ERG fusion is frequently observed in gleason pattern 3 prostate cancer in a canadian cohort,” Cancer Biology and Therapy, vol. 8, no. 2, pp. 125–130, 2009. View at Google Scholar · View at Scopus
  21. S. A. Tomlins, D. R. Rhodes, J. Yu et al., “The role of SPINK1 in ETS rearrangement-negative prostate cancers,” Cancer Cell, vol. 13, no. 6, pp. 519–528, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S. R. Setlur, K. D. Mertz, Y. Hoshida et al., “Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer,” Journal of the National Cancer Institute, vol. 100, no. 11, pp. 815–825, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Momand, H. H. Wu, and G. Dasgupta, “MDM2—master regulator of the p53 tumor suppressor protein,” Gene, vol. 242, no. 1-2, pp. 15–29, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. S. S. Myatt and E. W. F. Lam, “The emerging roles of forkhead box (Fox) proteins in cancer,” Nature Reviews Cancer, vol. 7, no. 11, pp. 847–859, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Maeda, S. Nagata, C. D. Wolfgang, G. L. Bratthauer, T. K. Bera, and I. Pastan, “The T cell receptor γ chain alternate reading frame protein (TARP), a prostate-specific protein localized in mitochondria,” Journal of Biological Chemistry, vol. 279, no. 23, pp. 24561–24568, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. E. A. Morgan, S. S. Forootan, J. Adamson et al., “Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: potential prognostic marker and target for tumourigenicity-suppression,” International Journal of Oncology, vol. 32, no. 4, pp. 767–775, 2008. View at Google Scholar · View at Scopus